ReviewCancers2024

Unlocking Intracellular Oncology Targets: The Unique Role of Antibody-Based T-Cell Receptor Mimic (TCRm) Therapeutics in T-Cell Engagers (TCEs) and Antibody-Drug Conjugates (ADCs).

Jeffrey Molldrem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.